PRME
Prime Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.70
−0.27%Margins
Gross margin
-1025.6%
EBITDA margin
-4431.5%
EBIT margin
-4824.9%
Net margin
-4613.1%
FCF margin
-3850.9%
-472.0%
Return on equity
-75.4%
Return on assets
-129.0%
Return on invested capital
0.01x
Asset turnover
-$156.1M
Cash from operations
$0.52
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026